Oxidative Medicine and Cellular Longevity / 2018 / Article / Fig 7

Research Article

Citrus aurantium Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability

Figure 7

Serum ROS levels of osteosarcoma patients. CG-B, the patients before receiving placebo treatment. NG-B, the patients before receiving naringenin treatment. CG-A, the patients after receiving two-year placebo treatment. NG-B, the patients after receiving two-year naringenin treatment.
(a)
(b)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.